menu

pipeline

programs

Across all IMIDs indications, the first-ranked unmet need reported by physicians and patient is always the same:
safer drugs targeted for the mild-to-moderate forms of these diseases.
Our pipeline is being developed to bring several complementary solutions to this issue.
Join the expedition

We believe that this is the future of therapy and
we would be glad to discuss these opportunities with you

Let's team up

partnerships

Manufacturing Pilot Unit

Discover

contact

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.